IP Library Assignment 030182/0547
Patent Assignment
Reel/Frame 030182/0547

Assignment of Assignor's Interest

Recorded: 2013-04-09 Pages: 8
Assignor
ABBOTT LABORATORIES
Executed: 2012-08-01
Assignee
ABBVIE INC.
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, ILLINOIS, 60064
Covered Properties (64)
Antagonists of Melanin Concentrating Hormone Receptor
Patent: 6,921,821 →
Application: 10/459,682 →
Publication: US 2004/0106645
Fused Bicycloheterocycle Substituted Quinuclidine Derivatives
Patent: 7,160,876 →
Application: 10/744,208 →
Publication: US 2005/0137184
(2S)-Amino(Phenyl)Acetic Acid and Derivatives as ALPHA2DELTA Voltage-Gated Calcium Channel Ligands
Patent: 7,354,955 →
Application: 10/752,943 →
Publication: US 2005/0148615
Antibacterial Compounds
Patent: 7,196,200 →
Application: 10/762,002 →
Publication: US 2005/0159423
2-(6-{2-[(2R)-2-Methyl-1-Pyrrolidin-1-Yl]-Ethyl}-2-Naphthalen-2-Yl)-2H-Pyridazin-3-One Salts and Their Preparation
Patent: 7,145,005 →
Application: 10/843,917 →
Publication: US 2005/0256127
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
Patent: 7,259,186 →
Application: 10/880,851 →
Publication: US 2005/0148594
Novel Amides Useful for Treating Pain
Patent: 7,129,235 →
Application: 10/887,383 →
Publication: US 2005/0080095
Tetraline Derivatives as Ghrelin Receptor Modulators
Patent: 7,115,767 →
Application: 10/893,484 →
Publication: US 2005/0014794
Thienopyridine and Furopyridine Kinase Inhibitors
Patent: 7,202,363 →
Application: 10/899,168 →
Publication: US 2005/0043347
Anti-Infective Agents
Patent: 7,378,414 →
Application: 10/925,072 →
Publication: US 2005/0107364
Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-Iv (Dpp-Iv)
Patent: 7,205,409 →
Application: 10/935,053 →
Publication: US 2005/0131019
Substituted Diazabicycloalkane Derivatives
Patent: 7,399,765 →
Application: 10/942,035 →
Publication: US 2005/0101602
Ureas Having Antiangiogenic Activity
Patent: 7,592,466 →
Application: 10/961,362 →
Publication: US 2006/0160806
Macrocyclic Kinase Inhibitors
Patent: 7,163,939 →
Application: 10/980,740 →
Publication: US 2005/0215556
Hiv Protease Inhibiting Compounds
Patent: 7,834,043 →
Application: 11/008,713 →
Publication: US 2005/0148623
Hiv Protease Inhibiting Compounds
Patent: 8,193,227 →
Application: 11/009,841 →
Publication: US 2011/0003827
Hiv Protease Inhibiting Compounds
Patent: 7,696,226 →
Application: 11/010,177 →
Publication: US 2005/0159469
Spirocyclic Quinuclidinic Ether Derivatives
Patent: 7,045,530 →
Application: 11/013,193 →
Publication: US 2005/0137219
3-Quinuclidinyl Heteroatom Bridged Biaryl Derivatives
Patent: 7,241,773 →
Application: 11/015,157 →
Publication: US 2005/0137226
3-Quinuclidinyl Amino-Substituted Biaryl Derivatives
Patent: 7,309,699 →
Application: 11/015,158 →
Publication: US 2005/0159597
Antagonists of Melanin Concentrating Hormone Effects on the Melanin Concentrating Hormone Receptor
Patent: 7,049,307 →
Application: 11/020,464 →
Publication: US 2005/0187279
Antagonists of Melanin Concentrating Hormone Effects on the Melanin Concentrating Hormone Receptor
Patent: 7,071,182 →
Application: 11/022,453 →
Publication: US 2005/0277638
Amino-Substituted Tricyclic Derivatives and Methods of Use
Patent: 7,365,193 →
Application: 11/051,437 →
Publication: US 2005/0234031
Antibacterial Compounds
Patent: 7,135,468 →
Application: 11/051,907 →
Publication: US 2005/0234053
Naphthyridine-Based Antibacterial Compositions
Patent: 7,632,946 →
Application: 11/051,909 →
Publication: US 2007/0088040
Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-Iv (Dpp-Iv)
Patent: 7,348,346 →
Application: 11/075,319 →
Publication: US 2005/0209249
Tricyclic Pyrazole Kinase Inhibitors
Patent: 7,468,371 →
Application: 11/089,473 →
Publication: US 2006/0014816
Azacyclosteroid Histamine-3 Receptor Ligands
Patent: 7,345,034 →
Application: 11/096,382 →
Publication: US 2005/0227953
Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme
Patent: 7,880,001 →
Application: 11/119,022 →
Publication: US 2005/0277647
Amino-Tetrazoles Analogues and Methods of Use
Patent: 8,217,067 →
Application: 11/120,718 →
Publication: US 2007/0049584
Tri- and Bi-Cyclic Heteroaryl Histamine-3 Receptor Ligands
Patent: 7,205,316 →
Application: 11/123,324 →
Publication: US 2005/0272736
Bicyclic-Substituted Amines Having Cyclic-Substituted Monocyclic Substituents
Patent: 7,098,222 →
Application: 11/123,620 →
Publication: US 2005/0272728
Apoptosis Promoters
Patent: 7,767,684 →
Application: 11/127,940 →
Publication: US 2006/0128706
N-Sulfonylcarboximidamide Apoptosis Promoters
Patent: 7,585,858 →
Application: 11/138,717 →
Publication: US 2005/0272744
Apoptosis Promoters
Patent: 7,642,260 →
Application: 11/202,827 →
Publication: US 2006/0258657
Amino-Tetrazole Analogues and Methods of Use
Patent: 7,704,997 →
Application: 11/221,333 →
Publication: US 2006/0052374
Methods for Visualizing Crystals and Distinguishing Crystals from Other Matter Within a Biological Sample
Patent: 7,545,495 →
Application: 11/321,993 →
Publication: US 2006/0215156
Inhibitors of C-Jun N-Terminal Kinases
Patent: 7,888,374 →
Application: 11/337,862 →
Publication: US 2006/0173050
Apoptosis Promoters
Patent: 8,614,318 →
Application: 11/491,851 →
Publication: US 2007/0015787
Fused Bicycloheterocycle Substituted Quinuclidine Derivatives
Patent: 7,674,794 →
Application: 11/599,651 →
Publication: US 2007/0066592
Apoptosis Promoters
Patent: 7,973,161 →
Application: 11/600,445 →
Publication: US 2007/0072860
Antibacterial Compounds
Patent: 7,737,159 →
Application: 11/675,160 →
Publication: US 2007/0142353
Thienopyridine and Furopyridine Kinase Inhibitors
Patent: 7,737,160 →
Application: 11/675,183 →
Publication: US 2007/0155776
Sustained Release Formulations of Opioid and Nonopioid Analgesics
Patent: 8,541,026 →
Application: 11/737,914 →
Publication: US 2007/0281018
Fused Bicycloheterocycle Substituted Quinuclidine Derivatives
Patent: 7,655,657 →
Application: 11/789,949 →
Publication: US 2008/0064703
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
Application: 11/840,477 →
Publication: US 2008/0051411
Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-Iv (Dpp-Iv)
Patent: 7,671,076 →
Application: 12/022,813 →
Publication: US 2008/0119464
Amino-Substituted Tricyclic Derivatives and Methods of Use
Patent: 7,951,791 →
Application: 12/046,599 →
Publication: US 2008/0161281
Amino-Tetrazoles Analogues and Methods of Use
Patent: 7,723,367 →
Application: 12/051,565 →
Publication: US 2008/0171733
Anti-Infective Agents
Patent: 7,538,105 →
Application: 12/098,024 →
Publication: US 2008/0193413
Substituted Diazabicycloalkane Derivatives Having Affinity for Nicotinic Acetylcholine Receptors
Patent: 7,872,010 →
Application: 12/132,009 →
Publication: US 2008/0275048
Solid Pharmaceutical Dosage Formulation
Application: 12/190,252 →
Publication: US 2008/0299203
Methods of Use of Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme
Patent: 8,415,354 →
Application: 12/390,329 →
Publication: US 2009/0192141
Apoptosis Promoters
Patent: 8,084,607 →
Application: 12/390,945 →
Publication: US 2010/0022773
Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate
Application: 12/573,302 →
Publication: US 2010/0021393
Thienopyridine and Furopyridine Kinase Inhibitors
Patent: 8,273,736 →
Application: 12/623,026 →
Publication: US 2010/0069371
Apoptosis Promoters
Patent: 8,173,811 →
Application: 12/800,702 →
Publication: US 2010/0240715
HIV Protease Inhibiting Compounds
Application: 12/813,298 →
Publication: US 2010/0249181
Solid Pharmaceutical Dosage Form
Patent: 8,309,613 →
Application: 12/880,781 →
Publication: US 2011/0015216
Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme
Patent: 8,372,841 →
Application: 13/217,831 →
Publication: US 2012/0004206
Hiv Protease Inhibiting Compounds
Patent: 8,653,141 →
Application: 13/451,370 →
Publication: US 2013/0023463
Amino-Tetrazoles Analogues and Methods of Use
Patent: 8,546,374 →
Application: 13/544,387 →
Publication: US 2012/0329772
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
Application: 13/619,165 →
Publication: US 2013/0018101
Solid Pharmaceutical Dosage Form
Patent: 8,691,878 →
Application: 13/674,799 →
Publication: US 2013/0072508
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 11, 2010
From: ABBOTT GMBH & CO. KG
To: ABBOTT LABORATORIES
Reel/Frame 024065/0523 →
Assignment of Assignor's Interest Mar 11, 2010
From: ABBOTT LABORATORIES
To: FOURNIER LABORATORIES IRELAND LTD.
Reel/Frame 024067/0165 →
Assignment of Assignor's Interest Mar 11, 2010
From: ABBOTT LABORATORIES
To: FOURNIER LABORATORIES IRELAND LTD.
Reel/Frame 024068/0397 →
Assignment of Assignor's Interest Sep 27, 2013
From: ANDERSON, DAVID D.; BEUTEL, BRUCE A.; GU, YU-GUI; HINMAN, MIRA M.
To: ABBOTT LABORATORIES
Reel/Frame 031295/0877 →